In Vitro Activity of Novel β-Lactam/β-Lactamase Inhibitors Against Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> and <i>Enterobacterales</i> in Korea

In Vitro Activity of Novel β-Lactam/β-Lactamase Inhibitors Against Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> and <i>Enterobacterales</i> in Korea

<b>Background/Objectives:</b> Carbapenem-resistant <i>Enterobacterales</i> (CRE) and carbapenem-resistant <i>Pseudomonas aeruginosa</i> (CRPA) are challenging multidrug-resistant pathogens. This study evaluated the in vitro susceptibility of CRE and CRPA blood iso...

Full description

Saved in:

Bibliographic Details
Main Authors:	Seulgi Moon, Jongyoun Yi, Mee Kyung Ko, Yong Ki Sim, Kye-Hyung Kim
Format:	Article
Language:	English
Published:	MDPI AG 2025-06-01
Series:	Antibiotics
Subjects:	antimicrobial agents carbapenem resistance bacteremia β-lactamase inhibitors Korea susceptibility
Online Access:	https://www.mdpi.com/2079-6382/14/7/649
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Characteristics and Outcomes of Patients Treated with Carbapenem Versus Non-carbapenem Therapy for AmpC-Producing Enterobacterales Bacteremia: A Retrospective Study
by: Shuroug A. Alowais, et al.
Published: (2025-04-01)

Challenges of Carbapenem-Resistant <i>Enterobacteriaceae</i> in the Development of New β-Lactamase Inhibitors and Antibiotics
by: Pierre Leroux, et al.
Published: (2025-06-01)

Metallo-β-lactamase-mediated resistance among clinical carbapenem-resistant Pseudomonas aeruginosa isolates in northern Iran: A potential threat to clinical therapeutics
by: Abdol Ahad Dogonchi, et al.
Published: (2018-01-01)

Are New β-Lactam/β-Lactamase Inhibitor Combinations Promising Against Carbapenem-Resistant <i>K. pneumoniae</i> Isolates?
by: Ayşe Nur Ceylan, et al.
Published: (2025-02-01)

Effectiveness of traditional non-carbapenem β-lactams vs. novel β-lactams for the treatment of carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study
by: Namareq F. Aldardeer, et al.
Published: (2024-12-01)

Characterization of Metallo β-Lactamase Producing <i>Enterobacterales</i> Isolates with Susceptibility to the Aztreonam/Avibactam Combination
by: Brunella Posteraro, et al.
Published: (2024-12-01)

Combating Metallo-β-Lactamase-Producing <i>Pseudomonas aeruginosa</i>: The Fractional Inhibitory Concentration Index as a Tool to Evaluate Antibiotic Synergy
by: Guido Granata, et al.
Published: (2025-02-01)

Evolution of β-Lactam Antibiotic Resistance in <i>Proteus</i> Species: From Extended-Spectrum and Plasmid-Mediated AmpC β-Lactamases to Carbapenemases
by: Branka Bedenić, et al.
Published: (2025-02-01)

Antimicrobial Resistance and Mortality in Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> Infections in Southern Thailand
by: Parichart Chotimakorn, et al.
Published: (2025-03-01)

β-Lactam/β-Lactamase Inhibitor Combination Antibiotics Under Development
by: Angeliki Katsarou, et al.
Published: (2025-02-01)

Multiplex PCR for identification and β-lactam resistance gene detection in clinical isolates of Acinetobacter baumannii
by: Anh T Nguyen, et al.
Published: (2025-05-01)

Comparison of Carbapenem vs. Amikacin Antimicrobial Therapy for Pediatric Acute Pyelonephritis Caused by Extended-Spectrum Β-Lactamase-Positive Enterobacteriaceae
by: Burcu Ceylan Cura Yayla, et al.
Published: (2025-07-01)

Cefiderocol in Combating Carbapenem-Resistant <i>Acinetobacter baumannii</i>: Action and Resistance
by: Bahman Yousefi, et al.
Published: (2024-11-01)

Mortality of metallo-β-lactamase-producing Enterobacterales bacteremias with combined ceftazidime–avibactam plus aztreonam vs. other active antibiotics: a multicenter target trial emulationResearch in context
by: Ivan Alfredo Huespe, et al.
Published: (2025-09-01)

Non-carbapenem antimicrobial therapy in young infant with urinary tract infections caused by community-acquired extended-spectrum β-lactamase-producing Escherichia coli
by: Kyo Jin Jo, et al.
Published: (2021-05-01)

In Vitro Interactions Between Bacteriophages and Antibacterial Agents of Various Classes Against Multidrug-Resistant Metallo-β-Lactamase-Producing <i>Pseudomonas aeruginosa</i> Clinical Isolates
by: Paschalis Paranos, et al.
Published: (2025-02-01)

Phenotypic and Genomic Characterization of ESBL- and AmpC-β-Lactamase-Producing <i>Enterobacterales</i> Isolates from Imported Healthy Reptiles
by: Franziska Unger, et al.
Published: (2024-12-01)

Activity of β-Lactamase Inhibitor Combinations Against Enterobacterales Isolated from Patients with Intra-Abdominal Infection from United States Medical Centres (2019–2023)
by: Helio S. Sader, et al.
Published: (2025-05-01)

Approachable Synthetic Methodologies for Second-Generation <i>β</i>-Lactamase Inhibitors: A Review
by: Noor Fatima, et al.
Published: (2024-08-01)

Carbapenem Resistance in <i>Acinetobacter baumannii</i>: Mechanisms, Therapeutics, and Innovations
by: Joyce de Souza, et al.
Published: (2025-06-01)

Insights into the Rising Threat of Carbapenem-Resistant Enterobacterales and <i>Pseudomonas aeruginosa</i> Epidemic Infections in Eastern Europe: A Systematic Literature Review
by: Michal Piotrowski, et al.
Published: (2024-10-01)

Emergence of Tigecycline-Nonsusceptible Carbapenem-Resistant <i>Klebsiella pneumoniae</i> with Metallo-β-Lactamase and Transferable Ceftazidime-Avibactam Resistance in China
by: Yajuan Ni, et al.
Published: (2025-03-01)

Phenotypic characterization and colistin susceptibilities of carbapenem-resistant of Pseudomonas aeruginosa and Acinetobacter spp.
by: Srujana Mohanty, et al.
Published: (2013-11-01)

Fecal carriage of extended-spectrum β-lactamase-producing, and carbapenem-resistant gram-negative bacteria among hemodialysis patients in a palestinian tertiary care hospital
by: Abdullah Janem, et al.
Published: (2024-11-01)

Evaluation of Infections Caused by Carbapenem-Resistant <i>Pseudomonas aeruginosa</i>, <i>Acinetobacter baumannii</i>, and <i>Klebsiella pneumoniae</i> in an Intensive Care Unit: A Retrospective Study
by: Elif Kerimoglu, et al.
Published: (2025-07-01)

High-risk Pseudomonas aeruginosa clones harboring β-lactamases: 2024 update
by: Verónica Roxana Flores-Vega, et al.
Published: (2025-01-01)

Elucidation of critical chemical moieties of metallo-β-lactamase inhibitors and prioritisation of target metallo-β-lactamases
by: Jung Hun Lee, et al.
Published: (2024-12-01)

Nosocomial blood-stream infections from extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumonia from GB Pant Hospital, New Delhi
by: Juhi Taneja, et al.
Published: (2010-04-01)

Comparative evaluation of five β-Lactamase inhibitors in combination with β-Lactams against multidrug-resistant Mycobacterium tuberculosis in vitro
by: Jie Shi, et al.
Published: (2025-04-01)

blaIMP and blaVIM mediated carbapenem resistance in Pseudomonas and Acinetobacter species in India
by: M Shanthi Amudhan, et al.
Published: (2012-11-01)

Detection of carbapenemase production in Enterobacterales by mCIM and eCIM: a tertiary care hospital study
by: Touseefa Shafi, et al.
Published: (2025-07-01)

Combined dual β-lactams and diazabicyclooctane β-lactamase inhibitor is highly effective against Mycobacterium abscessus species in vitro
by: Kana Misawa, et al.
Published: (2025-05-01)

7-<i>O</i>-Carboxylic Acid-Substituted 3-<i>O</i>-Alkyl Difluoroquercetin; An Aztreonam-Potentiating Agent Against Carbapenemase-Producing <i>Pseudomonas aeruginosa</i> Through Simultaneous Inhibition of Metallo-β-Lactamase and Efflux Pump
by: Seongyeon Lee, et al.
Published: (2024-12-01)

DETECTION OF bla-VIM1GENE IN CARBAPENEMRESISTANT Pseudomonas aeruginosa ISOLATED FROM CLINICAL SAMPLES IN WASIT PROVINCE HOSPITALS
by: Zeyad Khalaf Hussein, et al.
Published: (2018-11-01)

Combatting <i>Pseudomonas aeruginosa</i> with β-Lactam Antibiotics: A Revived Weapon?
by: Dylan W. Zhao, et al.
Published: (2025-05-01)

High prevalence of carbapenem-resistant Pseudomonas aeruginosa and identification of a novel VIM-type metallo-β-lactamase, VIM-92, in clinical isolates from northern China
by: Linbo Zhao, et al.
Published: (2025-02-01)

Assessment of in vitro antimicrobial activities of ceftolozane/tazobactam and ceftazidime/avibactam against carbapenem-resistant Pseudomonas aeruginosa clinical isolates
by: Dalia Salem, et al.
Published: (2025-04-01)

First report of a carbapenem-resistant Aeromonas veronii environmental isolate in the United States co-harboring two carbapenemase genes
by: Rafael Estrada, et al.
Published: (2024-12-01)

Enhanced removal of β-lactam antibiotics from synthetic wastewater via bioaugmentation of MBBR by MBL-positive Pseudomonas aeruginosa
by: Mohammad Javad Shokoohizadeh, et al.
Published: (2025-07-01)

Predictors of mortality from extended-spectrum beta-lactamase-producing Enterobacteriaceae bacteremia
by: Hiroki Namikawa, et al.
Published: (2023-12-01)